Launch of Unique Rat / Mouse PINP Assay
Immunodiagnostic Systems Holdings plc (IDS), a leading producer of diagnostic testing kits for the clinical and research markets, announces the launch of the worlds first assay for Rat/Mouse Type I procollagen amino-terminal propeptide (PINP), a biomarker for bone formation.
IDS designs, develops, manufactures and markets a wide range of immunoassay kits, and is particularly active in the field of Bone & Mineral metabolism with a growing presence in the field of Cancer Research.
Dr Roger Duggan, Managing Director of IDS, said, “This unique product fills a longstanding gap in the armoury of researchers seeking to understand the mechanisms of bone formation, and will aid in the identification of modulators of the growth of bone and of bone metastases. The launch of rat/mouse PINP also restates the commitment of IDS to the field of Bone & Skeletal biology and our ability to meet the needs of big Pharma. On a different level, the launch is particularly pleasing for IDS, as it represents the first successful launch of a new analyte developed by a Finnish consultant, in association with our subsidiary, SBA Sciences, acquired in 2005.”
Immunodiagnostic Systems Holdings plc
Parkgreen Communications Ltd
Dr. Roger Duggan, Managing Director
Tel: 0191 519 0660
Tel: 020 7851 7480
Mob: 07980 541 893